CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+10.75%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$3.07B
AUM Growth
+$3.07B
(+4.8%)
Cap. Flow
-$86.2M
Cap. Flow
% of AUM
-2.81%
Top 10 Holdings %
Top 10 Hldgs %
63.06%
Holding
43
New
2
Increased
11
Reduced
8
Closed
4
Top Buys
| 1 |
Medtronic
MDT
|
$52.9M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$41.4M |
| 3 |
Globus Medical
GMED
|
$41.4M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$28.5M |
| 5 |
Herbalife
HLF
|
$25.5M |
Top Sells
| 1 |
Sanofi
SNY
|
$80.9M |
| 2 |
Tenet Healthcare
THC
|
$52.9M |
| 3 |
Sarepta Therapeutics
SRPT
|
$40.1M |
| 4 |
CONMED
CNMD
|
$33.8M |
| 5 |
Zimmer Biomet
ZBH
|
$29.1M |
Sector Composition
| 1 | Healthcare | 97.08% |
| 2 | Consumer Staples | 1.66% |
| 3 | Consumer Discretionary | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Universal Health Services
UHS
$11.6B
| $304M | 9.89% | 1,925,000 | – | – |
|
|
2
Tenet Healthcare
THC
$16.3B
| $260M | 8.48% | 3,200,000 -650,000 | -17% | -$52.9M |
|
3
Viatris
VTRS
$12.3B
| $225M | 7.31% | 22,500,000 | – | – |
|
|
4
Sanofi
SNY
$121B
| $216M | 7.02% | 4,000,000 -1,500,000 | -27% | -$80.9M |
|
|
WBA
5
DELISTED
Walgreens Boots Alliance
WBA
| $214M | 6.96% | 7,500,000 +1,000,000 | +15% | +$28.5M |
|
6
Myriad Genetics
MYGN
$593M
| $154M | 5.01% | 6,635,000 -365,000 | -5% | -$8.46M |
|
|
7
Zimmer Biomet
ZBH
$21B
| $153M | 4.98% | 1,050,000 -200,000 | -16% | -$29.1M |
|
8
GSK
GSK
$79.9B
| $146M | 4.76% | 4,100,000 -500,000 | -11% | -$17.8M |
|
9
Baxter International
BAX
$12.7B
| $137M | 4.45% | 3,000,000 | – | – |
|
10
Select Medical
SEM
$1.61B
| $129M | 4.2% | 4,050,000 -750,000 | -16% | -$23.9M |
|
11
Ionis Pharmaceuticals
IONS
$6.79B
| $103M | 3.34% | 2,500,000 +575,000 | +30% | +$23.6M |
|
12
PTC Therapeutics
PTCT
$3.92B
| $102M | 3.31% | 2,500,000 | – | – |
|
13
Perrigo
PRGO
$3.27B
| $84.9M | 2.76% | 2,500,000 | – | – |
|
14
Quanterix
QTRX
$211M
| $77.2M | 2.52% | 3,425,000 | – | – |
|
15
Brookdale Senior Living
BKD
$1.83B
| $76M | 2.47% | 18,000,000 | – | – |
|
16
Dentsply Sirona
XRAY
$2.85B
| $70.6M | 2.3% | 1,765,000 | – | – |
|
|
MRTX
17
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $65M | 2.12% | 1,800,000 +400,000 | +29% | +$14.5M |
|
|
18
Teva Pharmaceuticals
TEVA
$21.1B
| $64M | 2.08% | 8,500,000 +5,500,000 | +183% | +$41.4M |
|
|
19
Globus Medical
GMED
$8.27B
| $59.5M | 1.94% | 1,000,000 +695,000 | +228% | +$41.4M |
|
|
20
Medtronic
MDT
$119B
| $52.9M | 1.72% | +600,000 | New | +$52.9M |
|
|
21
Sarepta Therapeutics
SRPT
$1.78B
| $45.8M | 1.49% | 400,000 -350,000 | -47% | -$40.1M |
|
22
ZimVie
ZIMV
$532M
| $36.5M | 1.19% | 3,250,000 | – | – |
|
|
23
Herbalife
HLF
$1.01B
| $36.4M | 1.19% | 2,750,000 +1,925,000 | +233% | +$25.5M |
|
24
Replimune Group
REPL
$422M
| $36M | 1.17% | 1,550,000 +300,000 | +24% | +$6.97M |
|
25
Exelixis
EXEL
$10.1B
| $29.6M | 0.96% | 1,550,000 | – | – |
|